Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma

Metastatic melanoma remains the deadliest form of skin cancer. Immune checkpoint inhibition (ICI) immunotherapy has defined a new age in melanoma treatment, but responses remain inconsistent and some patients develop treatment resistance. The myriad of newly developed small molecular (SM) inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Chacon, Alexander C., Melucci, Alexa D., Qin, Shuyang S., Prieto, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005112/
https://www.ncbi.nlm.nih.gov/pubmed/33810078
http://dx.doi.org/10.3390/ijms22063228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005112/
https://www.ncbi.nlm.nih.gov/pubmed/33810078
http://dx.doi.org/10.3390/ijms22063228

Ejemplares similares